Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study

Vox Sanguinis

Volumn 97, Issue 3, 2009, Pages 260-267

  Garcia Erce J A ^a   Cuenca, J ^b   Haman Alcober, S ^b   Martinez A A ^b   Herrera, A ^b   Munoz M ^c,d  

^a Departments of Haematology

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c UNIVERSITY OF MÁLAGA   (Spain)

^d Campus de Teatinos   (Spain)

Author keywords

Allogeneic transfusion; Hip fracture; Intravenous iron; Recombinant human erythropoietin; Surgery delay; Transfusion protocol

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; CLAVULANIC ACID; CLOPIDOGREL; CYANOCOBALAMIN; DICLOFENAC; DIPYRONE; ENOXAPARIN; FERRIC HYDROXIDE SUCROSE; FOLIC ACID; HEMOGLOBIN; OXYGEN; PARACETAMOL; RECOMBINANT ERYTHROPOIETIN;

AGED; ARTICLE; BLOOD CONSERVATION; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HIP FRACTURE; HIP SURGERY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; VENOUS THROMBOEMBOLISM; WOUND INFECTION;

AGED; AGED, 80 AND OVER; ASCORBIC ACID; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; EPOETIN ALFA; FEMALE; FERRIC COMPOUNDS; FOLIC ACID; FRACTURE FIXATION, INTERNAL; GUIDELINE ADHERENCE; HIP FRACTURES; HOSPITALS, UNIVERSITY; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; VITAMIN B 12;

EID: 70349541035     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01200.x     Document Type: Article

References (40)

1. García-Erce JA, Cuenca J, Solano V : [Predictive factors for transfusion requirements in patients over 65 years old with subcapital hip fracture]. Med Clin (Barc) 2003 120 : 161 166
2. Gruson KI, Aharonoff GB, Egol KA, Zuckerman JD, Koval KJ : The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma 2002 16 : 39 44
3. Swain DG, Nightingale PG, Patel JV : Blood transfusion requirements in femoral neck fracture. Injury 2000 31 : 7 10
4. Dillon MF, Collins D, Rice J, Murphy PG, Nicholson P, Elwaine JM : Preoperative characteristics identify patients with hip fractures at risk of transfusion. Clin Orthop Relat Res 2005 439 : 201 206
5. Herrera A, Domingo J, Calvo A, Martínez AA, Cuenca J : A comparative study of trochanteric fractures treated with the Gamma nail or the proximal femoral nail. Int Orthop (SICOT) 2002 26 : 165 169
6. Adunsky A, Lichtenstein A, Mizrahi E, Arad M, Heim M : Blood transfusion requirements in elderly hip fracture patients. Arch Gerontol Geriatr 2003 36 : 75 81
7. Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J, Koval KJ, Siu AL : Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture. Transfusion 2003 43 : 1358 1365
8. Morritt DG, Morritt AN, Kelley SP, Stone MH : Blood ordering protocol on proposed surgical implant in fracture neck of femur patients. Ann R Coll Surg Engl 2005 87 : 445 448
9. Johnston P, Wynn-Jones H, Chakravarty D, Boyle A, Parker MJ : Is perioperative blood transfusion a risk factor for mortality or infection after hip fracture? J Orthop Trauma 2006 20 : 675 679
10. Foss NB, Kristensen MT, Kehlet H : Anaemia impedes functional mobility after hip fracture surgery. Age Aging 2008 37 : 173 178
11. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H : The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion 2009 49 : 227 234
12. The Serious Hazards of Transfusion Steering Group. Annual report 2006. http://www.shotuk.org/SHOT-report-2006.pdf
13. Klein HG, Spahn DR, Carson JL : Red blood cell transfusion in clinical practice. Lancet 2007 370 : 415 426
14. Muñoz M, García-Erce JA, Villar I, Thomas D : Blood conservation strategies in major orthopaedic surgery. Efficacy, safety and European regulations. Vox Sang 2009 96 : 1 13
15. Muñoz M, Breymann C, García-Erce JA, Gómez- Ramírez S, Comin J, Bisbe E : Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008 94 : 172 183
16. García-Erce JA, Cuenca J, Muñoz M, Izuel M, Martinez AA, Herrera A, Solano VM, Martínez F : Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005 89 : 235 243
17. Weber EW, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E, van Os J, Vosmaer A, van der Ark P : Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005 22 : 249 257
18. British Committee for Standards in Haematology : Blood transfusion Task Force. Guidelines for the clinical use of red cell transfusion. Br J Haematol 2001 113 : 24 32
19. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG : Centres for Disease Control definitions of nosocomial surgical site infections, 1992. A modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992 13 : 606 608
20. Biesma DH, Van de Wiel A, Beguin Y, Kraaijenhagen RJ, Marx JJ : Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995 25 : 383 389
21. Van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel A : Iron metabolism and erythropoiesis after surgery. Br J Surg 1998 85 : 41 45
22. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P : Peri-operative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008 100 : 599 604 (Pubitemid 351774360)
23. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, Brett S, Goldhill DR, Soni N : Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006 90 : 105 112
24. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, Magaziner J, Merlino FE, Bunce G, McClelland B, Duff A, Noveck H : A pilot randomized trial comparing symptomatic vs. haemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998 38 : 522 529
25. Carson JL, Terrin ML, Magaziner J, Chaitman BR, Apple FS, Heck DA, Sanders D FOCUS Investigators : Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion 2006 46 : 2192 2206
26. Carson JL, Hill S, Carless P, Hébert P, Henry D : Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002 16 : 187 199
27. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP : Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003 54 : 908 914
28. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, Hudson JI, Provenzano G : Risk of bacterial infection associated with allogenic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999 39 : 694 700
29. Cuenca J, García-Erce JA, Martínez AA, Solano VM, Modrego JF : [Safety and utility of intravenous iron in acute anaemia after trochanteric hip fracture in the elderly. Preliminary data]. Med Clin (Barc) 2004 123 : 281 285
30. Cuenca J, García-Erce JA, Muñoz M, Izuel M, Martínez AA, Herrera A : Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004 44 : 1447 1452
31. Cuenca J, García-Erce JA, Martínez AA, Solano VM, Molina J, Muñoz M : Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair. Preliminary data. Arch Orthop Trauma Surg 2005 125 : 342 347
32. Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, Kalantar-Zadeh K : Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis 2008 52 : 727 736 AA, Francis CW, Culakova E, Lyman GH : Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 2005 104 : 2822 2829
33. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG : Prevention of venous thromboembolism. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 : 338S 400S
34. Izuel-Rami M, García-Erce JA, Gomez-Barrera M, Cuenca J, Abad R, Rabanaque MJ : [Relationship between allogeneic blood transfusion, iron deficiency and nosocomial infection in patients with hip fracture]. Med Clin (Barc) 2008 131 : 647 652
35. Izuel-Rami M, Gómez-Barrera M, Villar I, Rabaneque MJ, Cuenca J, García-Erce JA : [Budget impact analysis of a blood saving programme for urgent traumatological surgery]. Med Clin (Barc) 2007 128 : 7 11
36. Grimes JP, Gregory PM, Noveck H, Butler MS, Carson JL : The effects of time-to-surgery on mortality and morbidity in patients following hip fracture. Am J Med 2002 112 : 702 709
37. Moran CG, Wenn RT, Sikand M, Taylor AM : Early mortality after hip fracture: Is delay before surgery important? J Bone Joint Surg 2005 87-A : 483 489
38. Holt G, Smith R, Duncan K, Finlayson DF, Gregori A : Early mortality after surgical fixation of hip fractures in the elderly an analysis of data from the Scottish hip fracture audit. J Bone Joint Surg 2008 90-B : 1357 1363
39. Fleiss JL : Determining sample sizes needed to detect a difference between two proportions in : Fleiss JL Lewin B Chopaile M (eds) : Statistical Methods for Rates and Proportions, 2nd edn. New York : Wiley, 1981 : 38 45
40. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P : Peri-operative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008 100 : 599 604 (Pubitemid 351774360)